发明名称 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
摘要 The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N-fused-phenyl-N-benzyl aminoalcohols. A preferred specific N-fused-phenyl-N-benzyl aminoalcohol is the compound:
申请公布号 US6710089(B2) 申请公布日期 2004.03.23
申请号 US20020155311 申请日期 2002.05.23
申请人 PHARMACIA CORPORATION 发明人 SIKORSKI JAMES A.;DURLEY RICHARD C.;MISCHKE DEBORAH A.;REINHARD EMILY J.;FOBIAN YVETTE M.;TOLLEFSON MICHAEL B.;WANG LIJUAN;GRAPPERHAUS MARGARET L.;HICKORY BRIAN S.;MASSA MARK A.;NORTON MONICA B.;VERNIER WILLIAM F.;PARNAS BARRY L.;PROMO MICHELE A.;HAMME ASHTON T.;SPANGLER DALE P.;RUEPPEL MELVIN L.
分类号 B01D25/127;C07C215/08;C07C215/16;C07C217/58;C07C217/84;C07C217/88;C07C217/90;C07C217/92;C07C219/06;C07C219/28;C07C219/34;C07C225/22;C07C229/38;C07C229/52;C07C229/60;C07C233/25;C07C233/43;C07C233/69;C07C233/80;C07C235/20;C07C235/24;C07C235/56;C07C237/30;C07C237/38;C07C255/13;C07C255/21;C07C255/24;C07C255/54;C07C255/58;C07C271/28;C07C275/34;C07C275/40;C07C311/21;C07C311/58;C07C317/32;C07C317/36;C07C323/19;C07C323/20;C07C323/25;C07C323/31;C07C323/32;C07C323/37;C07C323/44;C07C323/65;C07C327/30;C07D207/32;C07D207/335;C07D209/82;C07D213/38;C07D213/62;C07D225/08;C07D239/26;C07D239/34;C07D251/46;C07D257/04;C07D263/04;C07D265/14;C07D277/28;C07D295/092;C07D295/108;C07D295/135;C07D295/192;C07D307/04;C07D307/38;C07D333/20;C07D333/28;C07D491/10;(IPC1-7):A61K31/136;A61K31/137;C07C215/20 主分类号 B01D25/127
代理机构 代理人
主权项
地址